|
KMID : 0370220210650030183
|
|
Yakhak Hoeji
2021 Volume.65 No. 3 p.183 ~ p.189
|
|
|
International Comparison of Generic Drugs Product Naming and Prescribing Method Registration Systems: United States of America, Japan, France, United Kingdom and South Korea
|
|
Chae Hong-Jo
Park Hye-Kyung
|
|
|
Abstract
|
|
|
To prevent errors in drug use, countries have defined certain rules to avoid confusion with other medicinesand have prohibited the insertion of phrases that may seem exaggerated in comparison to the actual effects of the drugs.
As more product names are licensed, there is an increasing chance that a product name may be similar to that of others.
To prevent this, some countries are naming generic drugs based on the name of the ingredient, pharmaceutical company,dosage form, and dose in accordance with certain rules. Each country also makes decisions consistent with the relevantregulations when naming ingredients, most of which are determined using International Nonproprietary Names (INN).
Currently, some countries are introducing an INN approval system that names generic drugs in the form of ‘INN’+‘dose’+‘pharmaceutical company name’+‘dosage form’ or implementing an INN prescription system, in which doctors writeINN without designating the brand name of pharmaceutical companies when issuing prescriptions. We surveyed productnaming of generic drugs and the prescribing method registration systems in the United States of America, Japan, France,the United Kingdom, and South Korea. The common reason each country introduced an INN system is to secure medicalinsurance finances by reducing drug costs through the active use of generic drugs. In addition, naming generic drugs usingINN should reduce accidents caused by medication errors owing to similar pronunciations between product names andingredient names or between different product names.
|
|
|
KEYWORD
|
|
|
generic naming, INN, INN prescribing, generic drug, generic substitution
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|